SymBiosis Capital Partners, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Rani Therapeutics Holdings, Inc. 13G/A
0753018100
4.4% 5/15/2026
Event 3/27/2026
Generation Bio Co. 13G/A
GBIO · 37148K209
6.3% 11/14/2025
Event 9/30/2025